About dātma
dātma is a company based in Beaverton (United States) founded in 2016 by Kemal Sonmez, Christopher Corless, and Ganapati Srinivasa. dātma has raised $2.5 million across 4 funding rounds from investors including National Science Foundation. dātma offers products and services including datma.FED, datma.BASE, and datma.360. dātma operates in a competitive market with competitors including Strand Life Sciences, Genuity Science, ICarbonX, Cellworks and Omega Therapeutics, among others.
- Headquarter Beaverton, United States
- Founders Kemal Sonmez, Christopher Corless, Ganapati Srinivasa
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Omics Data Automation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.5 M (USD)
in 4 rounds
-
Latest Funding Round
$2.5 M (USD), Seed
Dec 17, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of dātma
dātma offers a comprehensive portfolio of products and services, including datma.FED, datma.BASE, and datma.360.
Secure platform for sharing healthcare data between labs and companies.
System for ingesting and harmonizing multimodal healthcare data.
Tool for consolidating and analyzing healthcare data sources.
People of dātma
Unlock access to complete
Unlock access to complete
Funding Insights of dātma
dātma has successfully raised a total of $2.5M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $2.5 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in dātma
dātma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for dātma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by dātma
Investment portfolio details for dātma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - dātma
Detailed financials for dātma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dātma Comparisons
Peer comparison for dātma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of dātma
dātma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Genuity Science, ICarbonX, Cellworks and Omega Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Bioinformatics platforms are provided for health management and drug development.
|
|
| Locked | Locked | Locked |
Biosimulation platform developed for therapeutic design in life sciences.
|
|
| Locked | Locked | Locked |
Platform for human genome study is provided for precision medicine.
|
|
| Locked | Locked | Locked |
Integrated genomic analysis platform for epigenome data is provided.
|
Detailed competitors of dātma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dātma
Complete news archive for dātma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about dātma
dātma was founded in 2016 and raised its 1st funding round 1 year after it was founded.
dātma is headquartered in Beaverton, United States. It is registered at Beaverton, Oregon, United States.
Noah Nasser is the current CEO of dātma.
dātma is a funded company, having raised a total of $2.5M across 4 funding rounds to date.
dātm was founded in 2016 and is based in Beaverton, United States. Tools are offered by the company in the precision medicine sector to support clinics with data harmonization, visualization, sharing, and analysis. Omics data automation is enabled through products including dātm.BASE, dātm.360, and dātm.FED, bridging research applications to clinical use. Operations focus on software solutions for healthcare decision support.
dātma's top competitors include Strand Life Sciences, Omega Therapeutics and Cellworks.
dātma offers datma.FED, datma.BASE, and datma.360.
dātma has 1 investor. Key investors include National Science Foundation.